who should not take semaglutide Woman shares journey of weight loss and gain after using Semaglutide: Double-edged Sword with Risks

These are not published studies

191 The mechanism of GLP-1 RA to improve dopaminergic degeneration and pathological -synuclein aggregation in the PD model may involve inhibiting the PI3K/Akt/mTOR pathway 192 and enhancing AMPK/PGC-1a signaling pathway

The target timeline for Health Canadas scientific review of generic drug submissions is 180 days, Johnson said

Official as of November 1, 2023

In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver failure, lung failure, cardiac arrest, aspiration pneumonia and shock

This can help people lose weight and improve their blood sugar levels